- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
INDIVA (TSXV:NDVA) has been mentioned in an article published by WeedReader regarding why Jeff Sessions rescinding the Cole Memo makes Canada the perfect place to invest into Cannabis.
INDIVA (TSXV:NDVA) has been mentioned in an article published by WeedReader regarding why Jeff Sessions rescinding the Cole Memo makes Canada the perfect place to invest into Cannabis.
According to the author, the cannabis industry in Canada is not only a much safer alternative for investors then United States, but also more profitable.
The article describes Indiva, an Ontario-based cultivator that just raised over $23 million and is now increasing its production to a sizeable 40,000 square feet which is receiving significant attention from domestic and international investors.
The article further talks about R&D being a major factor for investment in producers like Indiva.
“The Canadian market is based around federally licensed producers, meaning that both LPs and patients have been given the right to produce and consume medical marijuana at the federal level,” said Indiva CEO Niel Marotta.
To read the full article, click here.
Click here to connect with INDIVA (TSXV:NDVA) to receive an Investors Presentation.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.